AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Uribegro 25mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Tas Med India Pvt Ltd

Salt Composition

Mirabegron (25mg)

Overview Uribegro 25mg Tablet ER

Extended-release Uribegro 25mg tablets manage overactive bladder symptoms such as frequent urination, urgency, and incontinence. This medication relaxes bladder muscles, improving urine storage capacity. Always adhere to your prescribed dosage and duration. Uribegro 25mg ER tablets may be taken with or without food; swallow whole, avoiding crushing or chewing. Discontinuing treatment prematurely may worsen symptoms; complete the prescribed course for optimal results. Common side effects include constipation, headache, hypertension, nasal congestion, urinary tract infections, tachycardia, and arthralgia. Report persistent or bothersome side effects to your physician immediately. Before starting treatment, disclose all other medications and pre-existing health conditions, including pregnancy or breastfeeding. Patients with hepatic or renal impairment require careful monitoring and regular physician check-ups.

Primary Ingredients of Uribegro 25mg Tablet ER

There is no text provided to rephrase.

Uses of Uribegro 25mg Tablet ER

Managing symptoms associated with overactive bladder

Major Benefits of Uribegro 25mg Tablet ER:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Uribegro 25mg Extended-Release Tablets can be administered with or without food, although consistent timing is recommended.

Common Side effects of Uribegro 25mg Tablet ER:

  • Constipation
  • Headache
  • High blood pressure
  • Nasal inflammation
  • Urinary tract infection
  • Fast heart rate
  • Joint pain

How to use Uribegro 25mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Uribegro 25mg Extended-Release tablet whole; do not crush, chew, or break it. While it can be taken with or without food, consistency is key—take it at the same time each day.

How Uribegro 25mg Tablet ER works:

Uribegro 25mg Extended-Release tablets contain a beta-3 adrenergic agonist. This medication's mechanism involves stimulating bladder beta-3 receptors, leading to detrusor muscle relaxation and a reduction in urinary urgency, frequency, and incontinence.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Use of Uribegro 25mg Tablet ER with alcohol requires careful consideration. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Uribegro 25mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Uribegro 25mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Extended-release Uribegro 25mg tablets typically do not impair driving ability.

KidneyKidneyCAUTION

For patients with severely impaired kidney function, the extended-release Uribegro 25mg tablet requires careful administration. Dosage modification of Uribegro 25mg Tablet ER may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Uribegro 25mg Extended-Release tablets cautiously, potentially requiring dose modification. Consultation with a physician is advised. Uribegro 25mg Extended-Release tablets are contraindicated in patients exhibiting severe hepatic dysfunction.

What if you forget to take Uribegro 25mg Tablet ER :

Should you forget a dose of Uribegro 25mg Extended-Release Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Uribegro 25mg Tablet ER

LabelValue
Chemical Type Anilide-based compound
Developing Habits No.
Type of Therapy Urologic Care
Active Class Beta-3 agonist for bladder control

FAQs on Uribegro 25mg Tablet ER

Optimal effects from Uribegro 25mg Tablet ER may become apparent after eight weeks or more of treatment. Dosage adjustments may be considered after four to eight weeks, based on individual response.
Continue taking your Uribegro 25mg Extended-Release tablets, even if your symptoms improve. This medication manages overactive bladder symptoms—urgency, frequency, and incontinence—but doesn't provide a cure. Stopping treatment could cause your symptoms to return.
Uribegro 25mg ER tablets shouldn't disrupt your sleep. Consult your doctor about any sleep-related issues.
Uribegro 25mg Tablet ER should not be used in children under 18 years of age, as its safety and efficacy haven't been established in this population.
Daily use, as prescribed, is essential. This medication manages your condition, not curing it. Intermittent use prevents your bladder from adapting fully, leading to ineffective treatment and symptom recurrence.
Uribegro 25mg Tablet ER may cause urinary tract infections (kidneys, ureters, bladder, or urethra) in some patients, though not all. Renal stones and bladder pain have been rarely reported. Patients with impaired kidney function should use caution and promptly report any kidney-related side effects to their doctor.
Uribegro 25mg Tablet ER may raise blood pressure; monitor your blood pressure regularly if you have hypertension. This medication is contraindicated in patients with severe, uncontrolled hypertension.
Seek immediate medical help, regardless of whether you feel any symptoms. Uribegro 25mg Tablet ER overdose can elevate heart rate and blood pressure, potentially causing severe headache, palpitations, chest pain, and fatigue.
Uribegro 25mg Tablet ER
207
MRP 239
13% off